文献速递产科母胎医学

扩展性无创产前检测与羊膜腔穿刺 blinded 对比研究

Extended Non-Invasive Prenatal Testing for Chromosomal and Monogenic Disorders by Cell-Free DNA Sequencing: A Blinded Comparison With Amniocentesis.
PubMed 文献 · Prenat Diagn · 2026-10-20

该研究为前瞻性、盲法、单中心配对样本诊断准确性研究,纳入641例因临床指征在16-18周转诊行羊膜腔穿刺的连续妊娠。比较分子整合无创胎儿外显子组测序(iNIFS)与羊膜腔穿刺的一致性,结果显示iNIFS与羊膜腔穿刺高度一致,敏感性99.1%,特异性99.6%,但阳性发现仍需侵入性确认。

要点

  • iNIFS在624/641例中可报告,612例有完整配对数据。
  • iNIFS与羊膜腔穿刺一致性高,敏感性99.1%、特异性99.6%。
  • 阳性发现仍需多中心验证和侵入性确认。

核心结论

  • 分子iNIFS在染色体、拷贝数和单基因发现方面与羊膜腔穿刺高度一致,同时保留明确的无结果率。
  • 阳性发现仍需多中心验证和侵入性确认。

研究设计与样本

  • 前瞻性、盲法、单中心配对样本诊断准确性研究,纳入641例因临床指征在16-18周转诊行羊膜腔穿刺的连续妊娠。
  • 血浆游离DNA进行低深度全基因组测序检测非整倍体和CNV,短片段富集后行亲-胎三人组临床外显子组测序。
  • 参考标准包括羊水DNA的QF-PCR、核型分析、微阵列比较基因组杂交及必要时三人组临床外显子组测序。

主要发现

  • iNIFS在624/641例妊娠中可报告(97.3%);612例(95.5%)有完整配对数据并构成分析人群。
  • 参考标准在107/612例(17.5%)中确定致病或可能致病变异。
  • NIPT结果为106例真阳性、503例真阴性、2例不一致阳性、1例不一致阴性;敏感性99.1%(95%CI 94.9-99.8),特异性99.6%(95%CI 98.6-99.9),PPV 98.1%(95%CI 93.5-99.5),NPV 99.8%(95%CI 98.9-100.0),一致性99.5%,Cohen's κ 0.98。
  • 不一致阴性为母源遗传变异,是区分母源与胎儿贡献最具挑战性的类别。

临床怎么用

  • iNIFS可作为产前筛查工具,高一致性支持其用于染色体、拷贝数和单基因异常的检测。
  • 阳性发现仍需通过羊膜腔穿刺等侵入性方法确认。

局限性

  • 单中心研究,需多中心验证。
  • 存在无结果率(97.3%可报告)。
  • 母源遗传变异区分困难。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether molecular integrated non-invasive fetal exome sequencing (iNIFS), using clinical exome sequencing of maternal-plasma cell-free DNA, concords per pregnancy with paired amniocentesis. METHOD: Prospective, blinded, single center, paired sample diagnostic accuracy study in 641 consecutive pregnancies referred for clinically indicated amniocentesis at 16-18 weeks. Plasma cell-free DNA underwent low-pass whole-genome sequencing for aneuploidies and CNVs and, after short-fragment enrichment, clinical exome sequencing within a parent fetus trio design. The reference standard comprised QF-PCR, karyotyping, array-comparative genomic hybridization and, where indicated, trio clinical exome sequencing on amniotic-fluid DNA. RESULTS: iNIFS was reportable in 624/641 pregnancies (97.3%); 612 (95.5%) had complete paired data and formed the analysis population. The reference established a pathogenic or likely pathogenic finding in 107/612 (17.5%). NIPT gave 106 true positives, 503 true negatives, 2 discordant positives and 1 discordant negative: sensitivity 99.1% (95% CI 94.9-99.8), specificity 99.6% (98.6-99.9), PPV 98.1% (93.5-99.5), NPV 99.8% (98.9-100.0), agreement 99.5% and Cohen's κ 0.98. The discordant negative was a maternally inherited variant, the class for which distinguishing maternal from fetal contributions is most challenging. CONCLUSION: Molecular iNIFS showed high concordance with paired amniocentesis across chromosomal, copy-number and monogenic findings, while retaining an explicit no call rate. Multicentre validation and invasive confirmation of positive findings remain necessary.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Mesoraca A, Margiotti K, Fabiani M, et al. Extended Non-Invasive Prenatal Testing for Chromosomal and Monogenic Disorders by Cell-Free DNA Sequencing: A Blinded Comparison With Amniocentesis. Prenat Diagn. 2026. PMID: 42900896. doi:10.1002/pd.70285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。